A finished D116 Task 1 example: one therapeutic class, its pharmacodynamics and pharmacokinetics, and a defended choice of agent set against the alternatives that were rejected. Searches like "d116 task 1 assignment example", "d116 task 1 sample" and "d116 task 1 example" land here.
What a finished D116 Task 1 drug class analysis looks like
The finished document is comparative from the first page. The class is named and bounded, so the reader knows which agents count as members and which sit in a neighboring class, and each member is described by mechanism at the target rather than by indication. Absorption, distribution, metabolism and elimination appear as properties that separate one agent from another, not as textbook headings filled in for their own sake. A comparison table often carries half-life, route, metabolic pathway and cost while the prose argues from it. Contraindications, boxed warnings and population cautions sit with the agents they belong to. The closing analysis names one agent as the reasonable first choice for a stated situation and says what each rejected agent would have cost.
How a D116 Task 1 example is structured
The example is built so the comparison has somewhere to land. It opens by defining the class and the clinical problem the class exists to solve, in a paragraph tight enough to leave room for the analysis. The second part handles shared mechanism, since agents in one class differ from each other only after the common action is settled. The third part splits the class agent by agent, and every agent is described on the same properties in the same order, which is what makes the later argument checkable. The fourth part introduces a stated patient situation, because a selection argument needs conditions to be right or wrong about. The fifth part reaches the choice and defends it, naming each alternative and the specific reason it was set aside. Monitoring attaches to the chosen agent rather than floating free.
The class bounded before it is compared
Membership is settled early, so the analysis does not slide between related classes when a convenient agent actually belongs somewhere else.
Same properties for every agent
Each member is described on an identical set of pharmacologic properties in a fixed order, which lets an evaluator check the comparison quickly.
Selection defended against named alternatives
The example says why one agent was chosen and what specifically disqualified each of the others for the situation described.
Warnings attached to the agent
Contraindications and boxed warnings appear beside the drug they apply to instead of collecting in a general safety paragraph at the end.
Prescribing references carry the claims
Current prescribing information and pharmacology literature support every pharmacokinetic figure, and no dose or interaction claim rests on a summary website.
Why D116 Task 1 comes back for revision
This task returns for revision when the analysis is a class description with a preference tacked on. The aspect asking for comparative reasoning needs the rejected agents present and named, so a paper that praises one drug and never says what the others would have cost leaves that aspect unmet. Missing pharmacokinetic detail is the second return: an evaluator reading for mechanism and disposition expects half-life, metabolism and elimination to do argumentative work rather than sit in a table nobody uses. A third comes from indication-based writing, where agents are separated by what they treat instead of by how they act. Precision decides this one, since aspects are met or not met and a longer paper does not compensate for a comparison that never happened.
Get a D116 Task 1 example written to your instructions
Send the D116 Task 1 instructions and the rubric aspects as your course of study states them, along with the class you were assigned or the one you intend to argue. We write a custom example to those aspects, with the selection defended against the agents it beat, and return it in 24-48h. The first custom sample is free.
D116 Task 1 questions, answered
Which drug class should I choose for D116 Task 1?
Whatever the instructions allow, chosen for how much published prescribing detail exists behind it. Antihypertensives, oral antidiabetic agents, anticoagulants, antidepressants and inhaled respiratory agents all give you enough separation between members to argue with. A class whose agents behave almost identically leaves the comparison aspect with nothing to reward, so pick one where the choice is genuinely contested.
How much pharmacokinetics does an evaluator expect?
Enough that the numbers change the argument. Half-life explains dosing interval, metabolic pathway explains interaction risk, and renal or hepatic elimination explains which patients cannot take the agent. Reciting all four processes for every drug without using any of them is the common excess. Follow your own rubric, since the depth expected does move between versions of this task.
Is any of this prescribing advice?
No. The example is a writing model for an academic submission, and nothing in it should be read as direction for treating a person. Doses and monitoring appear because the task asks for defended pharmacologic reasoning, not because the page recommends therapy. Practicum documentation, preceptor evaluations and site paperwork remain your own record, and we do not touch any of it.